Russian President Vladimir Putin. Photo: Alexei Druzhinin/TASS via Getty Images

On Dec. 1, Defense Secretary Mattis became the first Trump administration official to publicly confirm that the Kremlin continues to interfere in U.S. democracy, including in last month's midterm elections. Mattis has described Putin as a “slow learner,” but a new tracking project shows him to be an operator who has spent nearly two decades sharpening and deploying a set of asymmetric tools across the Atlantic.

The big picture: Election interference is just one part of Russia’s strategy. The Alliance for Securing Democracy has catalogued Kremlin fingerprints on over 400 incidents of interference in 42 countries. Beyond bots and troll farms, the toolbox includes information operations, cyberattacks, political subversion, strategic economic coercion and malign finance.

Russia's interference in Macedonia’s NATO accession efforts may seem unrelated to its malign finance campaign in Moldova, but deeper analysis shows these activities are part of a coordinated Kremlin effort to undermine democratic institutions throughout Europe and across the Atlantic. Rather than falling off after President Trump’s election in 2016, such efforts have continued apace, in a slow-burn destabilization strategy.

What to watch:

  • Escalating intensity of interference: Kremlin activities surged after the 2013 Euromaidan protests in Ukraine, suggesting it has come to rely more on these asymmetric tools, which come at minimal cost and offer a vital veneer of deniability.
  • Expanding geographic scope: Interference efforts prior to November 2013 targeted fewer than 30 transatlantic countries, mainly those within Russia’s “near-abroad” in Eastern Europe, the Caucasus and the Baltics. Since then, efforts have expanded to 42 transatlantic countries, with an increasing emphasis on Western Europe and North America.
  • Cyber and information operations: Since 2014, documented instances of cyberattacks and information operations (those making strategic, coordinated use of social or traditional media) have increased tenfold, indicating both the rising influence of the internet and the failure of democracies to deter action and secure vulnerabilities in cyberspace.

The bottom line: Moscow is playing a long game, and interference in specific elections is just one part of it. Getting ahead of the threat will therefore require Euro-Atlantic institutions to develop robust multilateral mechanisms to identify vulnerabilities and to coordinate rapid responses and effective deterrents.

Laura Rosenberger is director of the Alliance for Securing Democracy and a senior fellow at the German Marshall Fund of the United States.

Go deeper

Updated 56 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: FDA approves Gilead's remdesivir as a coronavirus treatment How the pandemic might endMany U.S. deaths were avoidable.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.

FBI: Russian hacking group stole data after targeting local governments

FBI Headquarters. Photo: Mark Wilson/Getty Images

Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.

Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.